HIV Infection in 2019: A Cure Is Not the Real News
Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, reacts to news of the London patient, the second person cured of HIV infection.
Intra-abdominal Infection With Eikenella corrodens in a Woman With Ovarian Cancer
“A bite bug in the belly.”
Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology
New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
Future of Fluoroquinolones: Risks, Benefits of Antibiotic Workhorse
Warnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.
Are Two Antibiotics Better Than One?
A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Treating Outpatient Cystitis in the Era of Antimicrobial Resistance
What can clinicians do now that increasing resistance has limited oral treatment options for outpatient cystitis?
The Case for On-Demand PrEP
What’s the 411 on 2-1-1?
Biktarvy: A Regimen of Choice for HIV Therapy
The new single-tablet regimen provides a safe and effective treatment option for patients with HIV.
Polyspecific Intravenous Immunoglobulin Plus Clindamycin for Streptococcal Toxic Shock Syndrome
Are there advantageous effects to use of adjunctive IVIG in the treatment of STSS with clindamycin?
PrEP Retention in Care—It Takes a Village
Incorporating clinical pharmacists and stewardship program oversights into PrEP models may improve the rate of retention in care.
2 Clarke Drive Cranbury, NJ 08512